From: MicroRNA genetic signature in non-small cell lung cancer (NSCLC) Egyptian patients
 | Control subjects, N = 30 | NSCLC patients, N = 37 | Test | P value |
---|---|---|---|---|
Gender | 18 males 12 females | 24 males 13 females | Chi-square | 0.940 |
Age (years) Mean ± SD | 58.30 ± 7.44 | 55.20 ± 9.34 | t test | 0.724 |
Smoking state | 15 smokers 15 non-smokers | 22 smokers 15 non-smokers | Chi-square | 0.8350 |
Histological type | Â | 17 (45.95%) SSC 16 (43.24%) AD 4 (10.81%) LCC | Â | Â |
TNM stage | Â | Stage I 8 (21.62%) Stage II 15 (40.54%) Stage III 9 (24.33%) Stage IV 5 (13.51%) | Â | Â |